These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 11735616

  • 21. Spotlight on rizatriptan in migraine.
    Wellington K, Jarvis B.
    CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863
    [Abstract] [Full Text] [Related]

  • 22. Zolmitriptan: a review of its use in migraine.
    Spencer CM, Gunasekara NS, Hills C.
    Drugs; 1999 Aug; 58(2):347-74. PubMed ID: 10473025
    [Abstract] [Full Text] [Related]

  • 23. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 24. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P, De Vries P, Saxena PR.
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introduction.
    Silberstein SD.
    Headache; 2002 Apr; 42 Suppl 2():S45-6. PubMed ID: 12028319
    [No Abstract] [Full Text] [Related]

  • 26. Frovatriptan as preemptive treatment for fasting-induced migraine.
    Latsko M, Silberstein S, Rosen N.
    Headache; 2011 Mar; 51(3):369-374. PubMed ID: 21269298
    [Abstract] [Full Text] [Related]

  • 27. Rizatriptan: a review of its efficacy in the management of migraine.
    Dooley M, Faulds D.
    Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
    [Abstract] [Full Text] [Related]

  • 28. Frovatriptan: a review of drug-drug interactions.
    Buchan P, Wade A, Ward C, Oliver SD, Stewart AJ, Freestone S.
    Headache; 2002 Apr; 42 Suppl 2():S63-73. PubMed ID: 12028322
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trials.
    Poolsup N, Leelasangaluk V, Jittangtrong J, Rithlamlert C, Ratanapantamanee N, Khanthong M.
    J Clin Pharm Ther; 2005 Dec; 30(6):521-32. PubMed ID: 16336284
    [Abstract] [Full Text] [Related]

  • 30. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
    Elkind AH, MacGregor EA.
    Expert Rev Neurother; 2008 May; 8(5):723-36. PubMed ID: 18457529
    [Abstract] [Full Text] [Related]

  • 31. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
    Allais G, Rolando S, De Lorenzo C, Benedetto C.
    Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381
    [Abstract] [Full Text] [Related]

  • 32. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC.
    Headache; 2009 Oct; 49(9):1283-97. PubMed ID: 19751371
    [Abstract] [Full Text] [Related]

  • 33. Frovatriptan: a review.
    Goldstein J.
    Expert Opin Pharmacother; 2003 Jan; 4(1):83-93. PubMed ID: 12517245
    [Abstract] [Full Text] [Related]

  • 34. Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future.
    Mitsikostas DD, Tfelt-Hansen P.
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):241-9. PubMed ID: 22934751
    [Abstract] [Full Text] [Related]

  • 35. [Frovatriptan possibly causing acute myocardial infarction].
    Møller-Helgestad OK, Kaltoft AK, Kasch H.
    Ugeskr Laeger; 2015 Mar 23; 177(13):V10140537. PubMed ID: 25822816
    [Abstract] [Full Text] [Related]

  • 36. A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.
    Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.
    J Headache Pain; 2011 Apr 23; 12(2):219-26. PubMed ID: 20686810
    [Abstract] [Full Text] [Related]

  • 37. Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans.
    Franconi F, Finocchi C, Allais G, Omboni S, Tullo V, Campesi I, Reggiardo G, Benedetto C, Bussone G.
    Neurol Sci; 2014 May 23; 35 Suppl 1(Suppl 1):99-105. PubMed ID: 24867845
    [Abstract] [Full Text] [Related]

  • 38. The truth about frovatriptan.
    Tfelt-Hansen P, Steiner T.
    Headache; 2003 Jun 23; 43(6):699-700; author reply 697-9. PubMed ID: 12786937
    [No Abstract] [Full Text] [Related]

  • 39. Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study.
    Newman LC, Harper S, Jones BA, Campbell J.
    J Womens Health (Larchmt); 2009 Aug 23; 18(8):1265-73. PubMed ID: 19627225
    [Abstract] [Full Text] [Related]

  • 40. Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline.
    Kelman L, Harper SQ, Hu X, Campbell JC.
    Curr Med Res Opin; 2010 Sep 23; 26(9):2097-104. PubMed ID: 20642390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.